Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Henan Dahe Pharmaceutical Co., Ltd. is a leading Chinese pharmaceutical enterprise primarily focused on the research, development, and large-scale production of pharmaceutical excipients and generic finished drugs. Established in 1992 and based in Zhumadian, Henan, the company is one of the largest manufacturers of Microcrystalline Cellulose (MCC) in Asia, holding a significant share of the domestic market. Its product portfolio includes a variety of cellulose-based excipients such as Croscarmellose Sodium and Silicified Microcrystalline Cellulose, alongside finished oral solid dosages for metabolic and cardiovascular health. Dahe Pharmaceutical operates under strict GMP guidelines and exports its products to numerous international markets, including North America and Europe. The company is recognized for its high-quality standards and serves as a key supplier to many global pharmaceutical firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dahe Pharmaceutical.